Bcl-2 is a better therapeutic target than c-Myc, but...

Experimental Hematology 2011 Vol. 39; Iss. 8

Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression

Nana Sasaki, Junya Kuroda, Hisao Nagoshi, Mio Yamamoto, Satoru Kobayashi, Yasuhiko Tsutsumi, Tsutomu Kobayashi, Yuji Shimura, Yosuke Matsumoto, Tomohiko Taki, Kazuhiro Nishida, Shigeo Horiike, Yukihir
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
39
Year:
2011
Language:
english
Pages:
7464
DOI:
10.1016/j.exphem.2011.05.002
File:
PDF, 1.37 MB
english, 2011
Conversion to is in progress
Conversion to is failed